Research, Science, Venture Capital

They are different streams of ideas. I was reading about the layoffs announced by various startups. To my limited understanding, these are punts made by multiple wealthy individuals which, if they work, provide a strategic “exit” to the founders making everyone rich. As such, there is a lot of money in “valuations”. These valuations depend […]

The Definitive Guide to Pricing Plans: Or why people make decisions the way they do.

It is one of the most fascinating reads in recent times. I was aware of dark matter in the user interfaces and constant notifications- based on exploitation of primaeval emotions like FaceBook does. I was trying to explore the correlation of social networks and how (and why) people take the decision to join one (or […]

Analysis paralysis

I stumbled on this wonderful link from an article somewhere and it completely encapsulates the feeling (I believe) that most of the people have: analysis paralysis. Here’s the gist: Analysis paralysis is when the fear of either making an error, or foregoing a superior solution, outweighs the realistic expectation or potential value of success in […]

In the Face of a Pandemic, Can Pharma Shift Gears?

    I have been mentioning earlier- the prices are “obscene” only because of perverted incentives. It is foolhardy to expect them to invest in diseases which are not of immediate concern and governments don’t see any “returns on investment”. Diabetes and Insulin (or conversely “biologicals”) will see higher rates of return for companies because […]

Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies

This was the only important key takeaway for medical imaging! As I have been mentioning it- AI has had the marketing component that’s been touted on social media, as the next “best thing”. I expect the madness to resume once the covid crisis wears off. I have annotated an accompanying editorial which merits a longer […]